AXM Pharma Issues Correction NEW YORK, July 06, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- AXM Pharma, Inc. (OTC:AXMP) (“AXM Pharma” or the “Company”) on July 02, 2018 announced that it entered into a binding letter agreement...

AXM Pharma Announces the Appointment of a New Chief Executive Officer NEW YORK, July 03, 2018 (GLOBE NEWSWIRE) -- AXM Pharma, Inc. (OTC:AXMP) (“AXM Pharma” or the “Company”) is pleased to announce that its Chairman, Mr. Emmanuel Neossi, has appointed Linda L. Forster...

AXM Pharma Announces A Proposed Reverse Merger with A Cameroon Billionaire Businessman NEW YORK, July 02, 2018 (GLOBE NEWSWIRE) -- AXM Pharma, Inc. (OTC:AXMP) (“AXM Pharma” or the “Company”) is pleased to announce that it has entered into a binding letter agreement dated as of June...